Who owns ZIOPHARM Oncology?

Key details on ZIOPHARM Oncology (Ticker: ZIOP)

Who owns ZIOPHARM Oncology?

Is ZIOP a good stock to own? Find out who bought ZIOPHARM Oncology, who sold ZIOPHARM Oncology (ZIOP) stock, and who holds a large position in ZIOPHARM Oncology.

Fund Name Number of Shares Share Valuation As Of
Third Security 9.69M $80.54M Dec. 31, 2015
Vanguard 6.39M $53.10M Dec. 31, 2015
MSDC Management 4.41M $39.72M Sept. 30, 2015
STATE STREET CORPORATION 4.19M $37.73M Sept. 30, 2015
LMM 3.95M $35.62M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 3.03M $25.16M Dec. 31, 2015
BlackRock Fund Advisors 2.88M $23.96M Dec. 31, 2015
Essex Woodlands Health Ventures 2.70M $13.69M Dec. 31, 2014
OrbiMed Advisors 2.54M $27.33M March 31, 2015
University of Texas Investment Management Company 2.50M $20.80M Dec. 31, 2015
Belmont Global Advisors 2.27M $10.40M March 31, 2014
FMR 1.84M $22.08M June 30, 2015
MORGAN STANLEY 1.62M $13.45M Dec. 31, 2015
Jennison Associates 1.52M $4.01M Sept. 30, 2014
NORTHERN TRUST 1.27M $11.49M Sept. 30, 2015
Austin W. Marxe and David M. Greenhouse 1.11M $6.05M Sept. 30, 2012
Barclays 1.04M $4.15M March 31, 2014
GOLDMAN SACHS 1.03M $12.38M June 30, 2015

Who sold ZIOPHARM Oncology?

Fund Name Date Sold Number of Shares Sold Share Valuation
QVT Financial June 30, 2011 1.06M $6.48M
Sunrise Partners Limited Partnership Dec. 31, 2010 1.21M $5.66M
Baker Bros. Advisors Dec. 31, 2010 1.04M $4.87M